Anticipatory management vs standard management of postpartum haemorrhage
Not Applicable
Not yet recruiting
- Conditions
- Postpartum haemorrhage (PPH)
- Registration Number
- SLCTR/2011/010
- Lead Sponsor
- Faculty of Medicine, Colombo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Giving birth after 36 Weeks of amenorrhea
•Post-partum haemorrhage due to uterine atony (recognized by continuing bleeding not responding to uterine massage and excluding other causes after examination)
Exclusion Criteria
•Anomalies of hemostasis before labour
•Anticoagulant treatment
•Patients with death in utero fetuses
•Diagnosed patients with placenta accreta or percreta
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie postpartum haemorrhage and potential targets for anticipatory management strategies?
How does anticipatory management compare to standard protocols in reducing postpartum haemorrhage severity and recurrence rates?
Are there specific biomarkers that identify patients likely to benefit from anticipatory management of postpartum haemorrhage?
What are the potential adverse events associated with anticipatory management approaches for postpartum haemorrhage?
What combination therapies or alternative interventions are being explored alongside anticipatory management for postpartum haemorrhage prevention?